Oxymed Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.20 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -2.10%
- Profit Growth -195.53%
- Ebitda -1.91%
- Net Worth -2.28%
- Total Assets -10.93%
About Oxymed Hospital
Oxymed Hospital Private Limited (OHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 December 2004 and has a history of 20 years and two months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ayaz Pasha, Saira Parveen, and Anvarsaleem Sanasaleem serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
- Apps
Corporate Identity Details
-
CIN/LLPIN
U85110TN2004PTC054774
-
Company No.
054774
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Oxymed Hospital?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayaz Pasha
|
Director | 01-Dec-2004 | Current |
|
Saira Parveen
|
Director | 15-Feb-2006 | Current |
|
Anvarsaleem Sanasaleem
|
Director | 30-Mar-2018 | Current |
Financial Performance of Oxymed Hospital.
Oxymed Hospital Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.1% decrease. The company also saw a substantial fall in profitability, with a 195.53% decrease in profit. The company's net worth dipped by a decrease of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oxymed Hospital?
In 2020, Oxymed Hospital had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Oxymed Hospital And Research Institute Private LimitedSaira Parveen is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oxymed Hospital?
Oxymed Hospital has a workforce of 48 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxymed Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxymed Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.